JNJ-7706621 is pan-CDK inhibitor with the highest potency on CDK1/2 with IC50 of 9 nM/4 nM and showing >6-fold selectivity for CDK1/2 than CDK3/4/6 in cell-free assays. It also potently inhibits Aurora A/B and has no activity on Plk1 and Wee1.
溫馨提示:JNJ-7706621,品質(zhì)穩(wěn)定,純度>98+%,僅供實(shí)驗(yàn)使用.產(chǎn)品質(zhì)量嚴(yán)格控制,保證品質(zhì)。
南京百鑫德諾生物科技有限公司
聯(lián)系商家時(shí)請?zhí)峒癱hemicalbook,有助于交易順利完成!